U.S. Capital Markets Stock News

Palladyne AI (PDYN) FY 2025 earnings snapshot Palladyne AI (PDYN) has wrapped up FY 2025 with fourth quarter revenue of US$1.7 million and a basic EPS loss of US$0.04, while the trailing twelve month figures show basic EPS of US$0.26. The company has seen quarterly revenue move from US$0.76 million in Q4 2024 to US$1.7 million in Q4 2025, alongside basic EPS shifting from a loss of US$1.82 to a loss of US$0.04 over the same period. This has set the stage for a year in which trailing twelve...

In recent weeks, Encompass Capital Advisors LLC increased its holdings in Luxembourg-based T1 Energy by acquiring an additional 21.5 million shares, bringing the asset manager’s stake to 9.53% of its reportable U.S. equity assets and making T1 Energy one of its largest positions. This sizable institutional commitment comes as T1 Energy, a lithium-ion battery cell manufacturer focused on energy storage, electric mobility, and marine applications, faces scrutiny from securities litigators and...

Commerce Bancshares (CBSH) is back on investors' radar after recent share price softness, with the stock down over the past week, month and past 3 months, prompting fresh questions about its current valuation. See our latest analysis for Commerce Bancshares. That recent dip fits into a wider cooling trend, with a 7 day share price return of 3.41% and a year to date share price return of 1.40%. The 1 year total shareholder return of 10.61% contrasts with a modest 3 year total shareholder...

Constellation Brands stock reaction Constellation Brands (STZ) has drawn investor attention after recent share price moves, with the stock down 2.6% over the past day and 5.4% over the past week. This invites a closer look at fundamentals. With US$9,383.0m in revenue and US$1,109.6m in net income, the company sits in the large cap bracket of the beer, wine, and spirits space, giving investors plenty of data to assess. See our latest analysis for Constellation Brands. Beyond the latest...

Cracker Barrel Old Country Store (CBRL) reported Q2 2026 revenue of US$874.8 million with basic EPS of US$0.06, as same restaurant sales came in with a 7.6% decline and net income excluding extra items totaled US$1.3 million. The company has seen quarterly revenue move from US$949.4 million in Q2 2025 to US$874.8 million in Q2 2026, while basic EPS shifted from US$1.00 a year ago to US$0.06 in the latest quarter, setting a very different earnings backdrop for investors to weigh. With trailing...

Unity Bancorp (UNTY) has just wrapped up FY 2025 with fourth quarter revenue of US$33.0 million and basic EPS of US$1.55, supported by trailing twelve month revenue of US$127.9 million and EPS of US$5.78. Over the past few reported periods, revenue has moved from US$27.1 million in Q4 2024 to US$33.0 million in Q4 2025, while quarterly EPS has shifted from US$1.15 to US$1.55, setting up a story where higher earnings are now flowing through a trailing net profit margin of 45.3%, which puts...

Medical Properties Trust (NYSE:MPT) has issued a response to Prospect Medical Group's bankruptcy filing. The company is outlining potential operational impacts related to Prospect's tenant status and leased hospital assets. Investors are watching for updates on rental income exposure, asset utilization, and any changes to existing lease arrangements. Medical Properties Trust focuses on owning and leasing hospital and healthcare facilities, so any disruption involving a key tenant like...

Bowman Consulting Group (BWMN) has wrapped up FY 2025 with fourth quarter revenue of US$129.0 million and basic EPS of US$0.11, alongside trailing twelve month EPS of US$0.74 on revenue of US$490.0 million. The company has seen quarterly revenue move from US$113.2 million in Q4 2024 to US$129.0 million in Q4 2025, while basic EPS shifted from US$0.35 to US$0.11 over the same period, with trailing twelve month EPS rising from US$0.18 to US$0.74. With earnings growth over the last year...

Kura Oncology (KURA) closed out FY 2025 with Q4 revenue of US$17.3 million and a basic EPS loss of US$0.92, alongside a net loss of US$81.0 million, while on a trailing twelve month basis revenue totalled US$67.5 million and EPS stood at a loss of US$3.18. Over the past six reported quarters, the company has seen quarterly revenue range from US$0 to US$53.9 million and basic EPS move between a loss of US$0.22 and a loss of US$0.92, giving investors a clear view of how the top line and per...

EyePoint Therapeutics (EYPT) closed FY 2025 with fourth quarter revenue of about US$0.6 million and a basic EPS loss of US$0.81, alongside a full year trailing twelve month basic EPS loss of US$3.17 and revenue of US$31.4 million. Over recent periods the company has seen quarterly revenue move from US$11.6 million in Q4 FY 2024 to US$24.5 million in Q1 FY 2025, then to US$5.3 million and US$1.0 million in Q2 and Q3 FY 2025, while basic EPS losses ranged between US$0.54 and US$0.85 per...

Cognizant Technology Solutions recently reshuffled its leadership in Asia Pacific & Japan, renewed a multi-million-dollar digital transformation partnership with Travel + Leisure Co., expanded its Google Cloud collaboration to scale agentic AI, and secured a multi-year AI-powered workplace modernization deal with a leading commercial vehicle manufacturer. Together, these moves highlight Cognizant’s push to embed AI and automation more deeply into large, long-term client relationships across...

Brilliant Earth Group (BRLT) has wrapped up FY 2025 with fourth quarter revenue of US$124.4 million and a basic EPS loss of US$0.19, alongside trailing twelve month revenue of US$437.5 million and a basic EPS loss of US$0.25. This sets a clear earnings reset for investors to assess. Over recent periods, the company has seen quarterly revenue move from US$119.5 million in Q4 2024 to US$124.4 million in Q4 2025. Basic EPS shifted from US$0.03 in Q4 2024 to a loss of US$0.19 in Q4 2025, and...

Perimeter Solutions (PRM) has drawn fresh attention after reporting fourth quarter and full year 2025 results, with higher sales alongside a swing from prior year profit to substantial net losses and wider losses per share. See our latest analysis for Perimeter Solutions. Those earnings arrived after a choppy stretch for the stock, with a 1 day share price return of 0.75% and 7 day return of 3.53% sitting against a 30 day decline of 8.60% and 90 day decline of 15.08%. At the same time, the 1...

PPL Corporation has completed a past US$1.00 billion composite corporate units offering of 20,000,000 equity/debt units priced at US$50.00 each with a US$0.94 per-unit discount, alongside reporting higher fourth-quarter and full-year 2025 sales, net income, and earnings per share from continuing operations. The company also raised its quarterly dividend by 4.6% to US$0.2850 per share and issued 2026 earnings guidance above 2025 results, highlighting confidence in its updated investment plan...

Aquestive Therapeutics (AQST) just wrapped up FY 2025 with Q4 total revenue of US$13.0 million and a basic EPS loss of US$0.26, alongside a trailing twelve month EPS loss of US$0.78 on US$44.5 million of revenue. The company has seen quarterly revenue move from US$8.7 million and a basic EPS loss of US$0.24 in Q1 2025 to US$10.0 million with a US$0.14 EPS loss in Q2, US$12.8 million with a US$0.14 EPS loss in Q3, and then US$13.0 million with a US$0.26 EPS loss in Q4. This leaves investors...

Recent commentary around U.S. Bancorp (USB) has focused on its earnings outlook, valuation metrics, and consistent capital returns, as investors weigh these factors alongside expectations for lower Federal Reserve interest rates and potential support for regional bank profitability. See our latest analysis for U.S. Bancorp. The recent 7 day share price return of a 5.85% decline and 1 month share price return of an 8.14% decline, against a current share price of $53.91, suggest momentum has...

If you are wondering whether RBC Bearings is still reasonably priced after its strong run, this article will walk through what the current share price might be baking in. The stock is now at US$566.06, after a 1.8% decline over the last 7 days, a 9.7% gain over 30 days, 23.4% year to date, 62.3% over 1 year and 146.3% over 3 years, with a 191.0% return over 5 years. Recent coverage around RBC Bearings has focused on its position in precision bearings and related components for industrial and...

DexCom’s recent stock performance in focus DexCom (DXCM) has drawn attention after recent share price moves, with the stock down about 3% over the past day and roughly 5% over the past week, prompting closer scrutiny from investors. See our latest analysis for DexCom. Looking beyond today’s move, DexCom’s 90 day share price return of 7.94% and year to date share price return of 6.24%, set against a 1 year total shareholder return of an 11.09% decline, suggests momentum has improved recently...

CPI Card Group's FY 2025 earnings snapshot CPI Card Group (PMTS) has wrapped up FY 2025 with fourth quarter total revenue of US$153.1 million and basic EPS of US$0.64, alongside net income of US$7.4 million that frames the latest read on profitability. Over recent periods, the company has seen quarterly revenue move from US$125.1 million and EPS of US$0.61 in Q4 2024 to US$153.1 million and EPS of US$0.64 in Q4 2025. The trailing twelve months show US$543.5 million of revenue and EPS of...

ChargePoint Holdings (CHPT) has wrapped up FY 2026 with fourth quarter revenue of US$109.3 million and a basic EPS loss of US$1.85, alongside a quarterly net loss of US$44.4 million. Over the past six quarters, the company has seen revenue move in a tight band from US$99.6 million in FY 2025 Q3 to US$109.3 million in FY 2026 Q4. Quarterly basic EPS losses ranged from US$1.85 to US$3.56, and quarterly net losses spanned US$44.4 million to US$77.6 million, highlighting a business still...

MediWound (NasdaqGM:MDWD) has just posted its FY 2025 numbers with Q4 revenue of US$1.9 million and a basic EPS loss of US$0.56, alongside full year trailing twelve month revenue of US$17.0 million and a net loss of US$23.9 million. Over recent periods, the company has seen quarterly revenue range from US$3.96 million to US$5.71 million with EPS moving between a loss of US$0.07 and US$1.23 per share. This sets the stage for a story that hinges on how quickly revenue growth can offset ongoing...

Janus International Group (JBI) has wrapped up FY 2025 with fourth quarter revenue of US$226.3 million and basic EPS of US$0.05, while trailing twelve month revenue came in at US$884.2 million and TTM EPS at US$0.39. Over recent periods the company has seen quarterly revenue move between US$210.5 million and US$230.8 million, with basic EPS ranging from roughly US$0.00 to US$0.15. This sets the backdrop for investors to judge how consistent profitability really looks. With a net profit margin...

Riley Exploration Permian (REPX) closed out FY 2025 with Q4 revenue of US$97.3 million and basic EPS of US$4.04, alongside full year trailing twelve month revenue of US$392.0 million and basic EPS of US$7.61. Over the last few quarters the company has seen revenue move from US$102.7 million in Q4 2024 to US$102.5 million in Q1 2025, US$85.4 million in Q2 2025, US$106.9 million in Q3 2025 and then US$97.3 million in Q4 2025, with quarterly EPS ranging from US$0.52 to US$4.04 over the same...

In its most recent quarter, Medpace Holdings reported US$708.5 million in revenue, a 32% year-on-year increase that surpassed analyst estimates by 3.3% and delivered the strongest growth and estimate beat among drug development inputs and services peers. The company’s decision to reinvest earnings instead of paying dividends, combined with its outperformance versus analyst organic revenue and full-year EPS forecasts, highlights a business model currently emphasizing expansion and operational...